EUVIMEDEUVIMED entdecken
Fallbericht

Treatment of Hyperlipidemia With Alirocumab in a Liver Transplant Recipient With Poor Blood Lipid Control: Case Report

Tie-Yan Fan, Yan Yan, Qian Lu, Jun Li, Hong Chen

Transplantation Proceedings · 2024

DOI: 10.1016/j.transproceed.2024.05.015 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Transplantation Proceedings, 2024. Verfasst von Tie-Yan Fan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Hepatobiliary and Pancreatic Center of Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Hyperlipidemias, Liver Transplantation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The use of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, such as alirocumab, to treat drug-resistant hypercholesterolemia is increasing; however, to date there have been no studies on the use of alirocumab to treat the hyperlipidemia that follows liver transplantation. Here we report a case of successful management of hyperlipidemia, albeit without total reversal of elevated serum triglycerides, with alirocumab monotherapy in a liver transplantation patient who was resistant to rosuvastatin and fenofibrate. In terms of safety, only transient palpitations following the first few alirocumab injections were recorded. This case illustrates that alirocumab can be a viable option for patients who experience poor lipid control after liver transplantation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, Monoclonal, HumanizedHyperlipidemiasLiver TransplantationHumansHypolipidemic AgentsPCSK9 InhibitorsTreatment Outcome

Substanzen

alirocumabAntibodies, Monoclonal, HumanizedHypolipidemic AgentsPCSK9 Inhibitors

Autor:innen und Institutionen

  • Hepatobiliary and Pancreatic Center of Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.
  • Department of Clinical Pharmacy of Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.
  • Hepatobiliary and Pancreatic Center of Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China. Electronic address: ch61520@163.com.

Zitieren

APA

Fan, T. Y., Yan, Y., Lu, Q., Li, J., & Chen, H. (2024). Treatment of Hyperlipidemia With Alirocumab in a Liver Transplant Recipient With Poor Blood Lipid Control: Case Report. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2024.05.015

Vancouver

Fan TY, Yan Y, Lu Q, Li J, Chen H. Treatment of Hyperlipidemia With Alirocumab in a Liver Transplant Recipient With Poor Blood Lipid Control: Case Report. Transplantation Proceedings. 2024. doi:10.1016/j.transproceed.2024.05.015

BibTeX
@article{Fan2024,
  author = {Fan, Tie-Yan and Yan, Yan and Lu, Qian and Li, Jun and Chen, Hong},
  title = {Treatment of Hyperlipidemia With Alirocumab in a Liver Transplant Recipient With Poor Blood Lipid Control: Case Report},
  journal = {Transplantation Proceedings},
  year = {2024},
  doi = {10.1016/j.transproceed.2024.05.015}
}
Kostenlos starten →